Literature DB >> 23835711

Induction chemotherapy meta-analysis in head and neck cancer: right answer, wrong question.

Arlene A Forastiere, David J Adelstein, Judi Manola.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23835711     DOI： 10.1200/JCO.2013.50.3136

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

1.  Concomitant chemoradiotherapy versus induction chemotherapy followed by chemoradiotherapy as definitive, first line treatment of squamous cell carcinoma of the head and neck. A retrospective single center analysis.

Authors:  P Balermpas; C Bauer; I Fraunholz; A Ottinger; J Wagenblast; T Stöver; O Seitz; E Fokas; C Rödel; C Weiss
Journal:  Strahlenther Onkol       Date:  2014-01-12       Impact factor: 3.621

2.  De-Escalated Adjuvant Therapy After Transoral Robotic Surgery for Human Papillomavirus-Related Oropharyngeal Carcinoma: The Sinai Robotic Surgery (SIRS) Trial.

Authors:  Brett A Miles; Marshall R Posner; Vishal Gupta; Marita S Teng; Richard L Bakst; Mike Yao; Kryzsztof J Misiukiewicz; Raymond L Chai; Sonam Sharma; William H Westra; Seunghee Kim-Schulze; Bheesham Dayal; Stanislaw Sobotka; Andrew G Sikora; Peter M Som; Eric M Genden
Journal:  Oncologist       Date:  2021-03-18

3.  Prognostic value of the radiomics-based model in progression-free survival of hypopharyngeal cancer treated with chemoradiation.

Authors:  Xiaokai Mo; Xiangjun Wu; Di Dong; Baoliang Guo; Changhong Liang; Xiaoning Luo; Bin Zhang; Lu Zhang; Yuhao Dong; Zhouyang Lian; Jing Liu; Shufang Pei; Wenhui Huang; Fusheng Ouyang; Jie Tian; Shuixing Zhang
Journal:  Eur Radiol       Date:  2019-10-30       Impact factor: 5.315

4.  Taxane-cisplatin-fluorouracil as induction chemotherapy for advanced head and neck cancer: a meta-analysis of the 5-year efficacy and safety.

Authors:  Xu Qian; Chenming Ma; Thomas K Hoffmann; Andreas M Kaufmann; Andreas E Albers
Journal:  Springerplus       Date:  2015-05-01

5.  The oncological outcome and influence of neoadjuvant chemotherapy on the surgery in the resectable and locally advanced oral squamous cell carcinoma.

Authors:  Xuan Su; Qing Liu; Jianyin Li; Chuyi Zhang; Zhuming Xue; Caiyun He; Weiwei Liu
Journal:  Cancer Manag Res       Date:  2019-07-25       Impact factor: 3.989

6.  Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303).

Authors:  H J Wanebo; J Lee; B A Burtness; J A Ridge; M Ghebremichael; S A Spencer; D Psyrri; E Pectasides; D Rimm; F R Rosen; M R Hancock; K A Tolba; A A Forastiere
Journal:  Ann Oncol       Date:  2014-07-09       Impact factor: 32.976

7.  The Role of 18-Fluoro-2-Deoxy-Glucose Positron Emission Tomography/Computed Tomography as Response and Prognosis Predictive Factor of Concurrent Chemoradiotherapy after Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Prospective Study.

Authors:  Severina Šedienė; Ilona Kulakienė; Viktoras Rudžianskas; Rita Ambrazienė
Journal:  Medicina (Kaunas)       Date:  2018-05-15       Impact factor: 2.430

8.  Widespread expression of Sonic hedgehog (Shh) and Nrf2 in patients treated with cisplatin predicts outcome in resected tumors and are potential therapeutic targets for HPV-negative head and neck cancer.

Authors:  Abu Shadat M Noman; Rashed R Parag; Muhammad I Rashid; Mohammad Z Rahman; Ali A Chowdhury; Afrin Sultana; Chandsultana Jerin; Ayesha Siddiqua; Lutfur Rahman; Afsana Shirin; Junayed Nayeem; Reaz Mahmud; Sonam Akther; Rajib K Shil; Ikram Hossain; Sharmin Alam; Arfina Chowdhury; Shabnam B Basher; Abul Hasan; Shammy Bithy; Jannatul Aklima; Mizanur Rahman; Nabila Chowdhury; Tahmina Banu; Bedri Karakas; Herman Yeger; Walid A Farhat; Syed S Islam
Journal:  Ther Adv Med Oncol       Date:  2020-03-13       Impact factor: 8.168
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.